Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Maeda

Showing results (61-70 of 233) with videos related to

Pageof 24
Sort By:
Biological & Pharmaceutical Bulletin|October 2, 2022
Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 InfectionYasuhiro Hayashi, Kouki Matsuda, Kazunari Tanigawa, et al.
Neuropsychopharmacology Reports|May 7, 2021
Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazoleTetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, et al.
Scientific Reports|July 8, 2024
Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutationsYoshiaki Yasutake, Shin-Ichiro Hattori, Hiroki Kumamoto, et al.
Cells|March 10, 2022
Lysosomal Changes in MitosisJonathan Stahl-Meyer, Lya Katrine Kauffeldt Holland, Bin Liu, et al.
Journal of General Internal Medicine|December 22, 2004
Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factorsYasuaki Hayashino, Sizuko Nagata-Kobayashi, Takeshi Morimoto, et al.
Molecular Cancer Therapeutics|July 10, 2019
Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca<sup>2+</sup> Release and Cyclic AMPAtul Anand, Bin Liu, Jano Dicroce Giacobini, et al.
Neuropsychopharmacology Reports|June 26, 2024
Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse modelsNaoki Amada, Shinji Sato, Dai Ishikawa, et al.
Antiviral Therapy|October 29, 2013
Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001Kenji Maeda, Darshan V Desai, Manabu Aoki, et al.
Neuropsychopharmacology Reports|March 7, 2026
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in RatsNaoki Amada, Mai Nakamura, Yuta Ohgi, et al.
Neurologia Medico-Chirurgica|March 29, 2011
Treatment of dural arteriovenous fistula presenting as typical symptoms of hydrocephalus caused by venous congestion: case reportYukiko Nakahara, Atsushi Ogata, Yukinori Takase, et al.
Pageof 24

Showing results (61-70 of 233) with videos related to

Sort By:
Pageof 24
Biological & Pharmaceutical Bulletin|October 2, 2022
Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 InfectionYasuhiro Hayashi, Kouki Matsuda, Kazunari Tanigawa, et al.
Neuropsychopharmacology Reports|May 7, 2021
Discovery research and development history of the dopamine D<sub>2</sub> receptor partial agonists, aripiprazole and brexpiprazoleTetsuro Kikuchi, Kenji Maeda, Mikio Suzuki, et al.
Scientific Reports|July 8, 2024
Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutationsYoshiaki Yasutake, Shin-Ichiro Hattori, Hiroki Kumamoto, et al.
Cells|March 10, 2022
Lysosomal Changes in MitosisJonathan Stahl-Meyer, Lya Katrine Kauffeldt Holland, Bin Liu, et al.
Journal of General Internal Medicine|December 22, 2004
Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factorsYasuaki Hayashino, Sizuko Nagata-Kobayashi, Takeshi Morimoto, et al.
Molecular Cancer Therapeutics|July 10, 2019
Cell Death Induced by Cationic Amphiphilic Drugs Depends on Lysosomal Ca<sup>2+</sup> Release and Cyclic AMPAtul Anand, Bin Liu, Jano Dicroce Giacobini, et al.
Neuropsychopharmacology Reports|June 26, 2024
Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse modelsNaoki Amada, Shinji Sato, Dai Ishikawa, et al.
Antiviral Therapy|October 29, 2013
Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001Kenji Maeda, Darshan V Desai, Manabu Aoki, et al.
Neuropsychopharmacology Reports|March 7, 2026
Synergistic Effect of Combination Treatment of Brexpiprazole and Nalmefene on Ethanol Intake in RatsNaoki Amada, Mai Nakamura, Yuta Ohgi, et al.
Neurologia Medico-Chirurgica|March 29, 2011
Treatment of dural arteriovenous fistula presenting as typical symptoms of hydrocephalus caused by venous congestion: case reportYukiko Nakahara, Atsushi Ogata, Yukinori Takase, et al.
Pageof 24